GCM2 and tumor of parathyroid gland: However, the higher rate of malignant and atypical parathyroid tumors in GCM2 mutation carriers is based on very few cases; thus, further studies and surveillance of GCM2 mutation carriers’ kindred are needed to confirm this association [11].